R&D
Multi-ComponentMulti-Target (MCMT) Approach
Solving the limitations of single-target
treatment for chronic incurable diseases
Development of disease modifying
natural drug products to treat chronic
incurable diseases
Platform Technology
AI-based big data system and
multi-omics analysis system analysis
Cutting edge CMC technology
which coincides with FDA regulations
SyMthomics
Multi-omics analysis based on AI-networking
modeling using virtual human body system
and clinical basis
Prediction of clinical efficacy by identifying
multi-components and mode of action(MoA)
Multi-Modality
Multi-component material using extracellular
vesicle of microbiome, exosome, etc.
Development of candidate material
to maximize clinical efficacy
